The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately.
SonoSite’s NanoMaxx Enters U.S.
The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately. International deliveries began in June. Featuring one-button optimization technology, the six pound NanoMaxx system will be marketed as a point-of-care system to hospitals and physician offices. The system, which boots up in less than 20 seconds, comes with five transducers to support thoracic assessment for pathology, vascular access, and needle aspirations and injections, as well as abdominal, cardiac, nerve, OB/Gyn, musculoskeletal, small parts and vascular scanning. NanoMaxx can be wall mounted, placed on an exam table with kickstand attached, used from a floor-based stand, or hand carried.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.